Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countries.

Background: Plaque psoriasis (PSO) is a long-term inflammatory condition that can cause concomitant joint symptoms (psoriatic arthritis [PsA]) in up to 30% of patients. The impact of psoriatic disease on disease outcomes and quality of life is greater in women than men.

Objective: We evaluated the impact of psoriatic disease on women aged 18 to 45 years across Europe.

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.

Importance: Therapies that reduce psoriasis symptoms may improve work productivity.

Objective: To assess the effect of ixekizumab therapy on work productivity, measured by the Work Productivity and Activity Impairment-Psoriasis (WPAI-PSO).

Design, Setting, And Participants: Three multicenter, randomized double-blind phase 3 trials conducted during the following periods: December 2011 through August 2014 (UNCOVER-1), May 2012 through April 2015 (UNCOVER-2), and August 2012 through July 2014 (UNCOVER-3).

Psoriasis and psycho-dermatology.

Introduction: Psoriasis is a common, long-term skin condition associated with high levels of psychological distress and considerable life impact. The impact of psoriasis, beyond the skin, is often not recognised and under-treated.

Methods: This paper explores the relationship between psychological distress and psoriasis including reference to the 'brain-skin access'.

Attitudes and beliefs of an albino population toward sun avoidance: advice and services provided by an outreach albino clinic in Tanzania.

Objective: To determine an albino population's expectations from an outreach albino clinic, understanding of skin cancer risk, and attitudes toward sun protection behavior.

Design: Survey, June 1, 1997, to September 30, 1997.

Setting: Outreach albino clinics in Tanzania.